[PDF] Top 20 Off-label drugs for weight management

... FDA label, and is intended to review some of the data on how US physicians are actually using drugs ...of drugs that are approved for other diseases that have weight loss as a side effect and ... See full document

... of off-label prescriptions in newborns derives in some cases by a lack of registered clinical trials [22], leading to absence of indication for use in this paediatric ...of off-label ... See full document

... 68. Goodyear MDE, Krleza-Jeric K, Lemmens T. The declaration of Helsinki. Brit Med J 2007; 335:624- 625; Nutt SL, B-cell identity - Commitment is not forever. New Eng J Med 2008; 358:82-83; McFarland HF. The B cell - Old ... See full document

... pursue drugs which have as many hard to pin down off-label uses as possible, since these are the least likely to be identifiable in the case of liability, and those that are most ...results: ... See full document

... of drugs prescribed have not been tested in children and safety and efficacy of children‘s medicines are frequently supported by low quality of ...an off- label or unlicensed basis. The ... See full document

... an off-label use that has been particularly concerning to regulators: using Seroquel for dementia-related psychosis in elderly ...that off-label use is a combination of two distinct ... See full document

... of off-label use were departments with a focus on the treat- ment of acute cases and emergencies (emergency unit, trauma surgery, intensive care, and neurology/stroke ...Psychiatric drugs in these ... See full document

... of drugs prescribed to children in this hospital, we prospectively gathered prescription data study in a dynamic ...age, weight, gender, diagnosis or reason of admission, drugs administered, form and ... See full document

... unapproved drugs often show early evidence of benefit reliable enough to use in desperately ill cancer patients” [28] or that “any glimmer of hope is better than none” ...Benchmark drugs and infusion ... See full document

... in off-label ...which drugs are dosed to achieve a certain range of concentrations in the blood with the understanding that these concen- trations reflect the concentrations at the drug’s site of ... See full document

... any off-label ...one off-label drug which is similar to the frequency of off-label use in patients with adverse drug ...of off-label drug was more among those ... See full document

... underrepresent off-label ...of off-label prescriptions, as clinicians may ignore prescriptions outside the dosage, routes of administration, or patient ...with off-label ... See full document

... new drugs and biological products that are likely to be commonly used in children, or that represent a meaningful therapeutic benefit over existing treatments for children, contain adequate pediatric labeling for ... See full document

... The proportion of patients receiving TCA were 16/81 (19.8 %) for depressive patients, 2/10 (20 %) for patients presenting an anxiety disorder, and 11/83 (13.3 %) among the patients with another disorder (Chi-square ... See full document

... The court found that the requirements, particularly the requirement that drug manufacturers file a supplemental application for the new use with the FDA, constituted [r] ... See full document

... time of the dose were not significantly associated with decreased blood-product requirements. From a resource use standpoint, there was an average 18 mL/kg decrease in blood-product administration per patient after ... See full document

... A total of 3182 subjects were enrolled and randomly assigned to receive lorcaserin 10 mg twice daily (n = 1595) or placebo (n = 1587) for 52 weeks. Thereafter, subjects on the active treatment were randomized to either ... See full document

... that off-label promotion represents a harm beyond the misbranding offense ...then, off- label promotion implicates three larger concerns: the rule of law, the relationship between regulators ... See full document

... the off-label use of many devices has become the most common and appropriate practice in pediatrics, often supported by published data, professional guidelines, and expert ... See full document

... on off-label use has not been carefully evaluated in a population- based ...assess off-label use of TCIs in children during periods before and after the FDA ’ s public health advisory and ... See full document